{"DataElement":{"publicId":"5875584","version":"1","preferredName":"Negation Food and Drug Administration Approval Test Kit Use Screening Type","preferredDefinition":"A description of the screening test(s) performed using a test kit that is not Food and Drug Administration approved.","longName":"5875296v1.0:5875309v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"5875296","version":"1","preferredName":"Negation Food and Drug Administration Approval Test Kit Use","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction._One of the agencies of the U.S. Department of Health and Human Services. It assures the safety of foods and cosmetics, and the safety and efficacy of pharmaceuticals, biological products, radiation emitting products, medical devices, and also, animal feed and drugs._Acceptance as satisfactory by an authoritative body; established by authority; given authoritative approval._A packaged system consisting of the main component materials necessary to perform one or more designated diagnostic tests or procedures._A manner, or usual, or accepted practice of using something.","longName":"5875294v1.0:2234899v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"5875294","version":"1","preferredName":"Negation Food and Drug Administration Approval Test Kit","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.:One of the agencies of the U.S. Department of Health and Human Services. It assures the safety of foods and cosmetics, and the safety and efficacy of pharmaceuticals, biological products, radiation emitting products, medical devices, and also, animal feed and drugs.:Acceptance as satisfactory by an authoritative body; established by authority; given authoritative approval.:A packaged system consisting of the main component materials necessary to perform one or more designated diagnostic tests or procedures.","longName":"C25594:C17237:C25425:C69035","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Food and Drug Administration","conceptCode":"C17237","definition":"One of the agencies of the U.S. Department of Health and Human Services. It assures the safety of foods and cosmetics, and the safety and efficacy of pharmaceuticals, biological products, radiation emitting products, medical devices, and also, animal feed and drugs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Approval","conceptCode":"C25425","definition":"Acceptance as satisfactory by an authoritative body; established by authority; given authoritative approval.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Test Kit","conceptCode":"C69035","definition":"A packaged system consisting of the main component materials necessary to perform one or more designated diagnostic tests or procedures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"52527C10-7821-2EDE-E053-F662850A2FDE","latestVersionIndicator":"Yes","beginDate":"2017-06-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-06-19","modifiedBy":"ONEDATA","dateModified":"2017-06-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2234899","version":"1","preferredName":"Use","preferredDefinition":"Use; put into service; make work or employ (something) for a particular purpose or for its inherent or natural purpose.","longName":"C25340","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Use","conceptCode":"C25340","definition":"A manner, or usual, or accepted practice of using something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9860F29-7486-7421-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-15","modifiedBy":"ONEDATA","dateModified":"2005-06-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435033","version":"1","preferredName":"Techniques","preferredDefinition":"A practiced and regimented skill or series of actions.","longName":"C16847","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87DA-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"52527C10-782F-2EDE-E053-F662850A2FDE","latestVersionIndicator":"Yes","beginDate":"2017-06-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-06-19","modifiedBy":"MALUMK","dateModified":"2020-08-04","changeDescription":"Released. 08/04/2020 KMM","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5875309","version":"1","preferredName":"Screening Type","preferredDefinition":"A systematic examination or assessment._Something distinguishable as an identifiable class based on common qualities.","longName":"5875309v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"HIV-1 NAT","valueDescription":"Human Immunodeficiency Virus 1 Nucleic Acid Amplification Test","ValueMeaning":{"publicId":"5875577","version":"1","preferredName":"Human Immunodeficiency Virus 1 Nucleic Acid Amplification Test","longName":"5875577","preferredDefinition":"The type species of lentivirus and the etiologic agent of acquired immunodeficiency syndrome (AIDS). It is characterized by its cytopathic effect and affinity for the T4-lymphocyte.: Any of various amplification and detection strategies applied to detection of virus contamination in donor blood.  Specifically designed to detect recently infected individuals during the latency period before seroconversion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Human Immunodeficiency Virus 1","conceptCode":"C14220","definition":"Any viral organism that can be assigned to the species Human Immunodeficiency virus 1.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Nucleic Acid Amplification Test","conceptCode":"C20055","definition":"Any of various amplification and detection strategies applied to detection of virus contamination in donor blood.  Specifically designed to detect recently infected individuals during the latency period before seroconversion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"52530D90-1D8D-6683-E053-F662850A0A2D","latestVersionIndicator":"Yes","beginDate":"2017-06-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-06-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"52530D90-1DA6-6683-E053-F662850A0A2D","beginDate":"2017-06-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-06-19","modifiedBy":"ONEDATA","dateModified":"2017-06-19","deletedIndicator":"No"},{"value":"Anti-HIV 1 and anti-HIV 2","valueDescription":"Human Immunodeficiency Virus 1 And Human Immunodeficiency Virus 2 Antibody","ValueMeaning":{"publicId":"5875578","version":"1","preferredName":"Human Immunodeficiency Virus 1 And Human Immunodeficiency Virus 2 Antibody","longName":"5875578","preferredDefinition":"The type species of lentivirus and the etiologic agent of acquired immunodeficiency syndrome (AIDS). It is characterized by its cytopathic effect and affinity for the T4-lymphocyte.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: An HIV species related to HIV-1 but carrying different antigenic components and with differing nucleic acid composition. It shares serologic reactivity and sequence homology with the simian Lentivirus SIV and infects only T4-lymphocytes expressing the CD4 phenotypic marker.: A protein made by plasma cells (a type of white blood cell) in response to an antigen (a substance that causes the body to make a specific immune response). Each antibody can bind to only one specific antigen. The purpose of this binding is to help destroy the antigen. Some antibodies destroy antigens directly. Others make it easier for white blood cells to destroy the antigen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Human Immunodeficiency Virus 1","conceptCode":"C14220","definition":"Any viral organism that can be assigned to the species Human Immunodeficiency virus 1.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Human Immunodeficiency Virus 2","conceptCode":"C14221","definition":"Any viral organism that can be assigned to the species Human Immunodeficiency virus 2.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Antibody","conceptCode":"C16295","definition":"A type of protein made by B lymphocytes in response to a foreign substance (antigen). Each antibody only binds to a specific antigen, helping to destroy the antigen directly or by assisting white blood cells to destroy the antigen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"52530D90-1DB5-6683-E053-F662850A0A2D","latestVersionIndicator":"Yes","beginDate":"2017-06-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-06-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"52530D90-1DCE-6683-E053-F662850A0A2D","beginDate":"2017-06-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-06-19","modifiedBy":"ONEDATA","dateModified":"2017-06-19","deletedIndicator":"No"},{"value":"Anti-HTLV I / II","valueDescription":"HTLV-1 And/Or HTLV-2 Antibody","ValueMeaning":{"publicId":"5875579","version":"1","preferredName":"HTLV-1 And/Or HTLV-2 Antibody","longName":"5875579","preferredDefinition":"A human deltaretrovirus related to HTLV-2. Human T-lymphotropic virus-1 (HTLV-1) is associated with adult T-cell leukemia (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).: Used to indicate that either or both of two items or options may be valid.: A human deltaretrovirus related to HTLV-1. Although human T-lymphotropic virus-2 (HTVL-2) has been isolated in association with specific diseases it has not been shown to have a causal relationship with any disease.: A protein made by plasma cells (a type of white blood cell) in response to an antigen (a substance that causes the body to make a specific immune response). Each antibody can bind to only one specific antigen. The purpose of this binding is to help destroy the antigen. Some antibodies destroy antigens directly. Others make it easier for white blood cells to destroy the antigen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"HTLV-1","conceptCode":"C14223","definition":"A human deltaretrovirus related to HTLV-2. Human T-lymphotropic virus-1 (HTLV-1) is associated with adult T-cell leukemia (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"And/Or","conceptCode":"C48928","definition":"Used to indicate that either or both of two items or options may be valid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"HTLV-2","conceptCode":"C14224","definition":"A human deltaretrovirus related to HTLV-1. Although human T-lymphotropic virus-2 (HTVL-2) has been isolated in association with specific diseases it has not been shown to have a causal relationship with any disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Antibody","conceptCode":"C16295","definition":"A type of protein made by B lymphocytes in response to a foreign substance (antigen). Each antibody only binds to a specific antigen, helping to destroy the antigen directly or by assisting white blood cells to destroy the antigen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"52530D90-1DDD-6683-E053-F662850A0A2D","latestVersionIndicator":"Yes","beginDate":"2017-06-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-06-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"52530D90-1DF6-6683-E053-F662850A0A2D","beginDate":"2017-06-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-06-19","modifiedBy":"ONEDATA","dateModified":"2017-06-19","deletedIndicator":"No"},{"value":"Chagas","valueDescription":"Chagas Disease","ValueMeaning":{"publicId":"3210951","version":"1","preferredName":"Chagas Disease","longName":"3210951","preferredDefinition":"A parasitic infection caused by Trypanosoma cruzi. It is transmitted by insect bites. It is characterized by an acute and chronic phase; in the acute phase patients may have fever, malaise, and swelling at the site of the insect bite. In the chronic phase patients develop hepatosplenomegaly, lymphadenopathy, cardiomyopathy and arrhythmias.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chagas Disease","conceptCode":"C84629","definition":"A parasitic infection caused by Trypanosoma cruzi. It is transmitted by insect bites. It is characterized by an acute and chronic phase; in the acute phase patients may have fever, malaise, and swelling at the site of the insect bite. In the chronic phase patients develop hepatosplenomegaly, lymphadenopathy, cardiomyopathy and arrhythmias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-B8E2-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"52532F2D-0433-711D-E053-F662850A09D4","beginDate":"2017-06-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-06-19","modifiedBy":"ONEDATA","dateModified":"2017-06-19","deletedIndicator":"No"},{"value":"WNV-NAT testing","valueDescription":"West Nile Virus Nucleic Acid Amplification Test","ValueMeaning":{"publicId":"5875580","version":"1","preferredName":"West Nile Virus Nucleic Acid Amplification Test","longName":"5875580","preferredDefinition":"A species of flavivirus, one of the Japanese encephalitis virus group. It can infect birds and mammals and is spread especially from birds to humans by mosquitoes. Human infection causes an illness marked by fever, headache, muscle ache, skin rash, and sometimes encephalitis or meningitis.: Any of various amplification and detection strategies applied to detection of virus contamination in donor blood.  Specifically designed to detect recently infected individuals during the latency period before seroconversion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"West Nile Virus","conceptCode":"C71877","definition":"A species of flavivirus, one of the Japanese encephalitis virus group. It can infect birds and mammals and is spread especially from birds to humans by mosquitoes. Human infection causes an illness marked by fever, headache, muscle ache, skin rash, and sometimes encephalitis or meningitis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Nucleic Acid Amplification Test","conceptCode":"C20055","definition":"Any of various amplification and detection strategies applied to detection of virus contamination in donor blood.  Specifically designed to detect recently infected individuals during the latency period before seroconversion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"52532F2D-0440-711D-E053-F662850A09D4","latestVersionIndicator":"Yes","beginDate":"2017-06-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-06-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"52532F2D-0459-711D-E053-F662850A09D4","beginDate":"2017-06-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-06-19","modifiedBy":"ONEDATA","dateModified":"2017-06-19","deletedIndicator":"No"},{"value":"Anti-CMV total","valueDescription":"Total Cytomegalovirus Antibody","ValueMeaning":{"publicId":"5875581","version":"1","preferredName":"Total Cytomegalovirus Antibody","longName":"5875581","preferredDefinition":"Pertaining to an entirety or whole, also constituting the full quantity or extent; complete; derived by addition.: Any immunoglobulin that recognizes the cytomegalovirus virus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Total","conceptCode":"C25304","definition":"Pertaining to an entirety or whole, also constituting the full quantity or extent; complete; derived by addition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cytomegalovirus Antibody","conceptCode":"C118487","definition":"Any immunoglobulin that recognizes the cytomegalovirus virus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"52532F2D-0466-711D-E053-F662850A09D4","latestVersionIndicator":"Yes","beginDate":"2017-06-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-06-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"52532F2D-047F-711D-E053-F662850A09D4","beginDate":"2017-06-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-06-19","modifiedBy":"ONEDATA","dateModified":"2017-06-19","deletedIndicator":"No"},{"value":"Syphilis","valueDescription":"Syphilis","ValueMeaning":{"publicId":"2577420","version":"1","preferredName":"Syphilis","longName":"2577420","preferredDefinition":"A contagious venereal disease caused by the spirochete TREPONEMA PALLIDUM.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Syphilis","conceptCode":"C35055","definition":"A contagious bacterial infection caused by the spirochete Treponema pallidum. It is a sexually transmitted disorder, although it can also be transmitted from the mother to the fetus in utero. Typically, it is initially manifested with a single sore which heals without treatment. If the infection is left untreated, the initial stage is followed by skin rash and mucous membrane lesions. A late stage follows, which is characterized by damage of the internal organs, including the nervous system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FB79-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-01-18","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-01-18","modifiedBy":"ONEDATA","dateModified":"2006-01-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"52532F2D-0489-711D-E053-F662850A09D4","beginDate":"2017-06-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-06-19","modifiedBy":"ONEDATA","dateModified":"2017-06-19","deletedIndicator":"No"},{"value":"HCV NAT","valueDescription":"Hepatitis C Virus Nucleic Acid Amplification Test","ValueMeaning":{"publicId":"5875310","version":"1","preferredName":"Hepatitis C Virus Nucleic Acid Amplification Test","longName":"5875310","preferredDefinition":"A small, enveloped, positive sense single strand RNA virus in the family Flaviviridae. The genome consists of a single RNA molecule with a single open reading frame.: Any of various amplification and detection strategies applied to detection of virus contamination in donor blood.  Specifically designed to detect recently infected individuals during the latency period before seroconversion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatitis C Virus","conceptCode":"C14312","definition":"A small, enveloped, positive sense single strand RNA virus in the family Flaviviridae. The genome consists of a single RNA molecule with a single open reading frame.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Nucleic Acid Amplification Test","conceptCode":"C20055","definition":"Any of various amplification and detection strategies applied to detection of virus contamination in donor blood.  Specifically designed to detect recently infected individuals during the latency period before seroconversion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5252E092-AA9C-2108-E053-F662850A8628","latestVersionIndicator":"Yes","beginDate":"2017-06-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-06-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5252E092-AAB5-2108-E053-F662850A8628","beginDate":"2017-06-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-06-19","modifiedBy":"ONEDATA","dateModified":"2017-06-19","deletedIndicator":"No"},{"value":"Anti-HCV","valueDescription":"Hepatitis C Antibody","ValueMeaning":{"publicId":"4396020","version":"1","preferredName":"Hepatitis C Antibody","longName":"4396020","preferredDefinition":"An antibody produced by B-lymphocytes in response to hepatitis C virus infection","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatitis C Antibody","conceptCode":"C116400","definition":"An antibody produced by B-lymphocytes in response to hepatitis C virus infection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEBEAA66-DEE6-868D-E040-BB89AD43726E","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"COLBERTM","dateCreated":"2014-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5252E092-AAC9-2108-E053-F662850A8628","beginDate":"2017-06-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-06-19","modifiedBy":"ONEDATA","dateModified":"2017-06-19","deletedIndicator":"No"},{"value":"HBV NAT","valueDescription":"Hepatitis B Virus Nucleic Acid Amplification Test","ValueMeaning":{"publicId":"5875311","version":"1","preferredName":"Hepatitis B Virus Nucleic Acid Amplification Test","longName":"5875311","preferredDefinition":"Hepatitis B Virus (HBV) is the prototype of the Hepadnavirus Family.  Included in the family are the Woodchuck Hepatitis Virus (WHV) and the Duck Hepatitis B Virus (DHBV) which provide animal models of infection.  The HBV genome is a partially double stranded circular DNA.  A viral reverse transcriptase is bound to the 5' extremity of the long strand.: Any of various amplification and detection strategies applied to detection of virus contamination in donor blood.  Specifically designed to detect recently infected individuals during the latency period before seroconversion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatitis B Virus","conceptCode":"C14215","definition":"Hepatitis B Virus (HBV) is the prototype of the Hepadnavirus Family.  Included in the family are the Woodchuck Hepatitis Virus (WHV) and the Duck Hepatitis B Virus (DHBV) which provide animal models of infection.  The HBV genome is a partially double stranded circular DNA.  A viral reverse transcriptase is bound to the 5' extremity of the long strand.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Nucleic Acid Amplification Test","conceptCode":"C20055","definition":"Any of various amplification and detection strategies applied to detection of virus contamination in donor blood.  Specifically designed to detect recently infected individuals during the latency period before seroconversion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5252E092-AAD6-2108-E053-F662850A8628","latestVersionIndicator":"Yes","beginDate":"2017-06-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-06-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5252E092-AAEF-2108-E053-F662850A8628","beginDate":"2017-06-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-06-19","modifiedBy":"ONEDATA","dateModified":"2017-06-19","deletedIndicator":"No"},{"value":"Anti HBc","valueDescription":"Hepatitis B Virus Core Antibody","ValueMeaning":{"publicId":"3370218","version":"1","preferredName":"Hepatitis B Virus Core Antibody","longName":"3370218","preferredDefinition":"An antibody produced by B lymphocytes to the hepatitis B core antigen as part of the immune response to hepatitis B viral infection.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatitis B Virus Core Antibody","conceptCode":"C62797","definition":"An antibody produced by B lymphocytes to the hepatitis B core antigen as part of the immune response to hepatitis B viral infection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B80317DA-47E1-5693-E040-BB89AD432471","latestVersionIndicator":"Yes","beginDate":"2012-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-02-02","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5252E092-AB03-2108-E053-F662850A8628","beginDate":"2017-06-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-06-19","modifiedBy":"ONEDATA","dateModified":"2017-06-19","deletedIndicator":"No"},{"value":"HBsAg","valueDescription":"Hepatitis B Surface Antigen","ValueMeaning":{"publicId":"3370219","version":"1","preferredName":"Hepatitis B Surface Antigen","longName":"3370219","preferredDefinition":"Any one of the hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatitis B Virus HBsAg Surface Protein Antigen","conceptCode":"C62786","definition":"Any one of the hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B80317DA-4804-5693-E040-BB89AD432471","latestVersionIndicator":"Yes","beginDate":"2012-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-02-02","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5252E092-AB0D-2108-E053-F662850A8628","beginDate":"2017-06-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-06-19","modifiedBy":"ONEDATA","dateModified":"2017-06-19","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435033","version":"1","preferredName":"Techniques","preferredDefinition":"A practiced and regimented skill or series of actions.","longName":"C16847","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87DA-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"5875308","version":"1","preferredName":"Screening Type","preferredDefinition":"A systematic examination or assessment.:Something distinguishable as an identifiable class based on common qualities.","longName":"C48261:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Screening","conceptCode":"C48261","definition":"A systematic examination or assessment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5252E092-AA72-2108-E053-F662850A8628","latestVersionIndicator":"Yes","beginDate":"2017-06-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-06-19","modifiedBy":"ONEDATA","dateModified":"2017-06-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5252E092-AA83-2108-E053-F662850A8628","latestVersionIndicator":"Yes","beginDate":"2017-06-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-06-19","modifiedBy":"MALUMK","dateModified":"2020-08-04","changeDescription":"Released 08/04/2020 KMM","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"What were the screening test(","type":"Preferred Question Text","description":"What were the screening test(s) performed using a test kit that is not Food and Drug Administration approved?","url":null,"context":"NHLBI"},{"name":"Specify which screening test(s) were performed using a test kit that is not FDA approved (non-FDA)","type":"Alternate Question Text","description":"Specify which screening test(s) were performed using a test kit that is not FDA approved (non-FDA)","url":null,"context":"NHLBI"},{"name":"Specify which screening test(s) were performed using a test kit that is not FDA approved","type":"Application Standard Question Text","description":"Specify which screening test(s) were performed using a test kit that is not FDA approved","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"52534B72-0686-4DF2-E053-F662850A2A08","latestVersionIndicator":"Yes","beginDate":"2017-06-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-06-19","modifiedBy":"MALUMK","dateModified":"2020-08-04","changeDescription":"Released. 08/04/2020 KMM; Released. 08/04/2020 KMM; System generated def displayed as alt def.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}